Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$23.66

0.2 (0.85%)

11:20
07/31/17
07/31
11:20
07/31/17
11:20

Vote of confidence in Myriad Genetics as shares advance

Vote of confidence in Myriad Genetics as shares advance. The stock up 65c to $24.31 and 6.8K Aug 21 puts sold at 20c per contract. 9.4K trade total against 218 open interest and the put writing comes ahead of an 8/8 profit report.

  • 31

    Jul

  • 08

    Aug

MYGN Myriad Genetics
$23.66

0.2 (0.85%)

03/13/17
SPHN
03/13/17
UPGRADE
SPHN
Overweight
Myriad Genetics upgraded to Overweight from Equal Weight at Stephens
03/28/17
DBAB
03/28/17
NO CHANGE
Target $15
DBAB
Sell
Zejula label removes upside catalyst for Myriad, says Deutsche Bank
Deutsche Bank analyst Dan Leonard says FDA approval of Tesaro's (TSRO) Zejula, with a "broad rather than biomarker-limited label," removes one potential upside catalyst for Myriad Genetics (MYGN). While some investors are surprised by the broad label, many had already discounted the possibility of a label that limited usage to biomarker positive patients, which would have benefited test-supplier Myriad, Leonard tells investors in a research note. The analyst keeps a Sell rating on Myriad with a $15 price target.
04/05/17
04/05/17
NO CHANGE

Myriad Genetics publishes pivotal studies for myPath melanoma test
Myriad Genetics has published the third clinical validation study and second clinical utility study for its myPath Melanoma test, which completes the reimbursement dossier for the product. The company will submit the reimbursement dossier to Medicare and private insurers three months earlier than expected. myPath Melanoma is an objective genetic test that measures 23 genes to help differentiate malignant melanoma from benign lesions. The third clinical validation was published in the journal Cancer Epidemiology, Biomarkers & Prevention. The study assessed the performance of the myPath Melanoma test in an independent cohort of 182 patients with melanocytic lesions against clinically proven outcomes. The results showed that the myPath Melanoma test had an overall diagnostic accuracy of 95% to effectively differentiate melanoma from benign lesions. The second clinical utility study was designed to evaluate changes in real world patient management based upon the myPath Melanoma test result. Results showed a 71% change in patient management from pre-test recommendations and an 81% reduction in biopsy site re-excisions for patients with a benign test result.
06/29/17
JPMS
06/29/17
NO CHANGE
Target $16
JPMS
Underweight
JPMorgan keeps Underweight rating, $16 target on Myriad Genetics
With the shares up 30% over the past month, JPMorgan analyst Tycho Peterson maintains an Underweight rating on Myriad Genetics with a $16 price target. While the company's pipeline "intriguing," it is not enough to offset a continued decline in the core hereditary cancer business, Peterson tells investors in a research note. He believes near-term catalysts could drive the stock "meaningfully higher or lower," and highlights the FY18 guidance in the Q4 earnings report as being the most significant upcoming event.

TODAY'S FREE FLY STORIES

INFY

Infosys

$14.79

-1.14 (-7.16%)

04:04
08/21/17
08/21
04:04
08/21/17
04:04
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 06

    Sep

CPN

Calpine

$14.92

1.42 (10.52%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Downgrade
Calpine rating change  »

Calpine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EL

Estee Lauder

$105.92

7.6 (7.73%)

04:02
08/21/17
08/21
04:02
08/21/17
04:02
Upgrade
Estee Lauder rating change  »

Estee Lauder upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOC

Physicians Realty Trust

$17.94

-0.24 (-1.32%)

04:01
08/21/17
08/21
04:01
08/21/17
04:01
Upgrade
Physicians Realty Trust rating change  »

Physicians Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBMD

Howard Bancorp

$18.05

0.65 (3.74%)

03:58
08/21/17
08/21
03:58
08/21/17
03:58
Upgrade
Howard Bancorp rating change  »

Howard Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

SNA

Snap-On

$147.96

-0.86 (-0.58%)

03:56
08/21/17
08/21
03:56
08/21/17
03:56
Downgrade
Snap-On rating change  »

Snap-On downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 06

    Sep

E

Eni SpA

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Eni SpA rating change  »

Eni SpA downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STO

Statoil

$18.41

0.31 (1.71%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Statoil rating change  »

Statoil downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REPYY

Repsol

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Repsol rating change  »

Repsol downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$50.49

0.61 (1.22%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Total rating change  »

Total downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSIQ

Canadian Solar

$16.63

0.23 (1.40%)

03:55
08/21/17
08/21
03:55
08/21/17
03:55
Downgrade
Canadian Solar rating change  »

Canadian Solar downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

03:43
08/21/17
08/21
03:43
08/21/17
03:43
Upgrade
Advance Auto Parts rating change  »

Advance Auto Parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOME

At Home Group

$22.53

-0.22 (-0.97%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
At Home Group initiated  »

At Home Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWW

Grainger

$161.39

-3.21 (-1.95%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Initiation
Grainger initiated  »

Grainger reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Jan

NKE

Nike

$54.95

-2.51 (-4.37%)

03:40
08/21/17
08/21
03:40
08/21/17
03:40
Downgrade
Nike rating change  »

Nike downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

03:40
08/21/17
08/21
03:40
08/21/17
03:40
General news
FX Action: USD-CAD has settled near 1.2600 »

FX Action: USD-CAD has…

03:05
08/21/17
08/21
03:05
08/21/17
03:05
General news
FX Update: The dollar majors traded without drama »

FX Update: The dollar…

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:25
08/20/17
08/20
20:25
08/20/17
20:25
Earnings
Notable company reporting before Monday's open »

The notable company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:16
08/20/17
08/20
20:16
08/20/17
20:16
Earnings
Breaking Earnings news story on 58.com »

58.com sees Q3 revenue up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

WUBA

58.com

$53.26

-0.23 (-0.43%)

20:11
08/20/17
08/20
20:11
08/20/17
20:11
Earnings
58.com reports Q2 EPS 55c, consensus 20c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

, LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

20:02
08/20/17
08/20
20:02
08/20/17
20:02
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SBUX

Starbucks

$52.70

-0.34 (-0.64%)

LMT

Lockheed Martin

$299.20

-2.22 (-0.74%)

GDI

Gardner Denver

$21.97

-0.03 (-0.14%)

CAH

Cardinal Health

$64.38

-0.78 (-1.20%)

PDCO

Patterson Companies

$36.45

-0.31 (-0.84%)

RMD

ResMed

$73.07

0.28 (0.38%)

ABC

AmerisourceBergen

$78.60

-1.34 (-1.68%)

UNH

UnitedHealth

$190.82

-1.88 (-0.98%)

AAP

Advance Auto Parts

$93.26

0.41 (0.44%)

MSI

Motorola Solutions

$87.37

0.24 (0.28%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

BGS

B&G Foods

$31.40

-0.3 (-0.95%)

MDLZ

Mondelez

$42.94

-0.47 (-1.08%)

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 29

    Aug

  • 06

    Sep

  • 11

    Sep

  • 14

    Sep

  • 18

    Sep

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Sep

  • 29

    Sep

  • 02

    Nov

  • 25

    Jan

SRE

Sempra Energy

$116.55

0.76 (0.66%)

, BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

18:47
08/20/17
08/20
18:47
08/20/17
18:47
Periodicals
Sempra Energy near deal to acquire Oncor Electric, Bloomberg reports »

Sempra Energy (SRE) is…

SRE

Sempra Energy

$116.55

0.76 (0.66%)

BRK.A

Berkshire Hathaway

$267,377.00

302 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Sep

TWX

Time Warner

$101.19

-0.42 (-0.41%)

, CMCSA

Comcast

$40.52

0.25 (0.62%)

18:34
08/20/17
08/20
18:34
08/20/17
18:34
Hot Stocks
Box Office Battle: 'Hitman's Bodyguard' wins weekend with $21.6M »

Lionsgate' (LGF.A)…

TWX

Time Warner

$101.19

-0.42 (-0.41%)

CMCSA

Comcast

$40.52

0.25 (0.62%)

CMCSK

Comcast

SNE

Sony

$38.77

-0.23 (-0.59%)

FOX

21st Century Fox

$26.79

-0.1 (-0.37%)

FOXA

21st Century Fox

$27.26

-0.09 (-0.33%)

LGF.A

Lionsgate

$28.41

0.37 (1.32%)

DIS

Disney

$100.70

-0.68 (-0.67%)

VIAB

Viacom

$28.59

-0.62 (-2.12%)

VIA

Viacom

$38.80

-3.6 (-8.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 27

    Sep

  • 29

    Sep

GME

GameStop

$21.22

0.12 (0.57%)

, MSFT

Microsoft

$72.49

0.09 (0.12%)

17:08
08/20/17
08/20
17:08
08/20/17
17:08
Hot Stocks
GameStop kicks off nationwide pre-orders for Microsoft Xbox One X »

GameStop (GME) is…

GME

GameStop

$21.22

0.12 (0.57%)

MSFT

Microsoft

$72.49

0.09 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 05

    Sep

GS

Goldman Sachs

$222.15

0.73 (0.33%)

16:48
08/20/17
08/20
16:48
08/20/17
16:48
Periodicals
Goldman Sachs receives approval to trade equities in Saudi Arabia, Reuters says »

Goldman Sachs has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.